IRON NASDAQ
Disc Medicine, Inc.
1W: -1.6%
1M: +19.0%
3M: +4.0%
YTD: -1.8%
1Y: -7.2%
3Y: +76.8%
5Y: +118.8%
$79.90
+2.24 (+2.88%)
After Hours: $78.00 (-1.90, -2.38%)
Weekly Expected Move ±20.5%
$44
$59
$75
$90
$105
Credit Risk of going bust: lower than 70% of companies Debt: 2.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.19 (down 99.8%), Disc Medicine, Inc. would be worth roughly what it owes.
Total debt $60.9M against a stock market value of $2.98B.
Distance to default 7.52 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $29.7M (short-term plus half of long-term), stock volatility 60.2%; Altman Z'' 8.69. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.19 (down 99.8%), Disc Medicine, Inc. would be worth roughly what it owes.
Total debt $60.9M against a stock market value of $2.98B.
Distance to default 7.52 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $29.7M (short-term plus half of long-term), stock volatility 60.2%; Altman Z'' 8.69. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$3.0B
52W Range40-99.5
Volume1,203,251
Avg Volume753,929
Beta2.11
Dividend—
Analyst Ratings
Company Info
CEOJohn D. Quisel
Employees165
SectorHealthcare
IndustryBiotechnology
IPO Date2020-08-12
Websitediscmedicine.com
321 Arsenal Street
Watertown, MA 02472
US
Watertown, MA 02472
US
617 674 9274
About Disc Medicine, Inc.
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Latest News
Majority of Disc Medicine 6M share offering goes to 10 investors: report
Disc Medicine sets $75 share price for $450M offering
Stock Traders Buy Large Volume of Put Options on Disc Medicine (NASDAQ:IRON)
Disc Medicine launches $350M public offering of common stock and pre-funded warrants
Disc Medicine surges on late-stage trial win for lead asset developed with Roche
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Bitterman Kevin | S-Sale | 13,783 | $80.23 | 2026-10-21 |
| Bitterman Kevin | S-Sale | 11,470 | $80.23 | 2026-10-21 |
| Bitterman Kevin | S-Sale | 266 | $80.23 | 2026-10-21 |
| Bitterman Kevin | S-Sale | 2,869 | $79.95 | 2026-10-20 |
| Bitterman Kevin | S-Sale | 2,388 | $79.95 | 2026-10-20 |